Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2020 Dec 17;296:100186. doi: 10.1074/jbc.RA120.016637

Allostery in the nitric oxide dioxygenase mechanism of flavohemoglobin

Anne M Gardner 1,2, Paul R Gardner 1,2,3,
PMCID: PMC7948479  PMID: 33310705

Abstract

The substrates O2 and NO cooperatively activate the NO dioxygenase function of Escherichia coli flavohemoglobin. Steady-state and transient kinetic measurements support a structure-based mechanistic model in which O2 and NO movements and conserved amino acids at the E11, G8, E2, E7, B10, and F7 positions within the globin domain control activation. In the cooperative and allosteric mechanism, O2 migrates to the catalytic heme site via a long hydrophobic tunnel and displaces LeuE11 away from the ferric iron, which forces open a short tunnel to the catalytic site gated by the ValG8/IleE15 pair and LeuE11. NO permeates this tunnel and leverages upon the gating side chains triggering the CD loop to furl, which moves the E and F-helices and switches an electron transfer gate formed by LysF7, GlnE7, and water. This allows FADH2 to reduce the ferric iron, which forms the stable ferric–superoxide–TyrB10/GlnE7 complex. This complex reacts with internalized NO with a bimolecular rate constant of 1010 M−1 s−1 forming nitrate, which migrates to the CD loop and unfurls the spring-like structure. To restart the cycle, LeuE11 toggles back to the ferric iron. Actuating electron transfer with O2 and NO movements averts irreversible NO poisoning and reductive inactivation of the enzyme. Together, structure snapshots and kinetic constants provide glimpses of intermediate conformational states, time scales for motion, and associated energies.

Keywords: flavohemoglobin, nitric oxide dioxygenase, hemoglobin, myoglobin, nitric oxide, oxygen, allostery, flavin, heme, electron transfer

Abbreviations: BSA, bovine serum albumin; Cygb, cytoglobin; ET, electron transfer; flavoHb, flavohemoglobin; Hb, hemoglobin; LT, long tunnel; Mb, myoglobin; Ngb, neuroglobin; ST, short tunnel; TMAO, trimethylamine-N-oxide; τT, transition time; Φdis, photodissociation; WT, wild-type


Distantly related members of the Hb superfamily, including flavoHb, HbN, phytoglobin, Mb, and Cygb, function as NO dioxygenases (NODs) (EC 1.14.12.17) to limit NO toxicity and control NO signaling in cells (1, 2). A greater understanding of the enzyme mechanism promises insights for the design of novel antibiotics, vasorelaxants, and antitumor agents. We previously suggested an ordered ping-pong mechanism in which O2 enters the distal pocket and binds the ferrous heme forming a stable ferric superoxide intermediate that reacts with NO to form NO3 and Fe3+, and in which Fe3+ is rapidly reduced to repeat the catalytic cycle (1, 2, 3, 4, 5, 6). In support of the mechanism, the conserved distal TyrB10 hydroxyl group in flavoHb and HbN confers high O2 affinity by stabilizing the proposed intermediate Fe3+O2 thus allowing rapid turnover (4, 7, 8, 9). Also, the ferric heme was shown to be reduced by NADH, in the absence of O2 or NO, at rates approaching NOD turnover rates suggesting an unregulated reduction step (4). However, the mechanism has failed to fully account for weak and reversible NO inhibition and a large O2 requirement relative to NO and O2 affinities measured for the ferrous heme (1, 4, 5, 10). Indeed, the relatively high affinity of ferrous flavoHbs for NO (4, 5) led Hausladen et al. (11) to suggest a reversed order ping-pong mechanism in which a ferric nitroxyl intermediate reacts with O2 to form NO3, a reaction with an intrinsically small rate constant that is inconsistent with the large NO dioxygenation rate constants of (flavo)Hbs and the critical role of O2 affinity in high turnover rates (1, 2). In addition, the 100-fold discrepancy between the NO migration rate to the ferrous heme as measured by transient kinetics and the calculated Vmax/Km(NO) or k'NOD values for flavoHb-NODs (4, 5) has demanded clarification. Deficiencies in both of the proposed mechanisms has spurred greater efforts toward a resolution (2, 12, 13, 14, 15, 16). Nevertheless, the mechanism has remained enigmatic, and controversial, partly because of the physical and chemical similarities of the substrates O2 and NO, and also because of insufficient knowledge of the unique structures and dynamics supporting the mechanism, and an apparent underdetermination of kinetic data (4). A simple ping-pong mechanism also fails to fully explain the dioxygenase activity of Cygb (10, 17) or the alpha subunit of HbA in complex with its chaperone (18). Both NOD activities would also be expected to be exquisitely sensitive to irreversible poisoning by NO. In fact, the well-known rapid and tight binding of NO with the ferrous heme of erythrocyte HbA or muscle Mb, with comparable O2 association and NO oxidation (dioxygenation) rate constants (19, 20), has long diminished enthusiasm for an enzymatic NOD function for Mb and HbA, or its subunits (2, 21) or, for that matter, any globin.

A greater understanding of the NOD mechanism, and a solution to the paradox, is slowly emerging from a wealth of structural models, molecular dynamics simulations, and spectroscopic and kinetic studies of globins. O2 and NO tunnels and a nitrate egress pathway have been suggested to play roles in the NOD function of the truncated HbN from Mycobacterium tuberculosis (22, 23). A long hydrophobic tunnel that runs parallel to the H helix and perpendicular to the heme plane is thought to allow NO (22, 24, 25), or O2 (1624, 26), to access the distal heme reaction chamber, while a short tunnel formed between the G and H helices at the AlaG5 and LeuH8 residues allows O2 (22), or NO (24, 26, 27), to access the distal heme pocket. Moreover, movement of PheE15 caused by O2 binding to the ferrous heme and TyrB10-GlnE11 hydrogen-bonding interactions (28) may function as a gate, in cooperation with LeuG8, that controls NO access to the heme (22, 25, 29, 30, 31). In support, a TrpE15 variant showed two- to threefold less NOD activity when reductively coupled and assayed within E. coli (30) but inexplicably showed no effect on NO dioxygenation by HbNFe3+O2 (32) and little apparent effect on O2 or NO migration to the ferrous heme (30). On the other hand, replacing LeuG8 with Phe or Trp caused large effects on CO rebinding kinetics (33), suggesting a preferential pathway for CO migration. Molecular dynamics simulations of HbN map a probable escape route for NO3 at the ThrE2 residue in the CD loop (34).

An important mechanistic clue has also been provided by studies of the mammalian Cygb-NOD. We and others have reported 10- to 100-fold larger rate constants for the ascorbate and cytochrome b5-mediated reduction of the ferric Cygb during NOD catalysis (10, 17). The data are explained if O2 and NO movements or reaction within Cygb serve as a trigger for electron transfer during catalysis (10). Evidence of an electron transfer trigger and switch would also explain how the reduction step limits the NOD function (4, 35). Furthermore, Cygb structures reveal potential tunnels and gates (36, 37) that appear functionally similar to those found in HbN.

We have observed, and now report, cooperative activation of the E. coli flavoHb-NOD activity by O2 and NO. To understand the apparent allostery, we have analyzed structures of flavoHbs, and related globins, formulated a structural and kinetic model for the NOD mechanism, and evaluated the model for its compatibility with the steady-state and transient kinetic behavior of wild-type (WT) and variant flavoHbs. The data and model allow us to derive kinetic constants and energies for a flavoHb-NOD mechanism that employs O2 (38) and NO-specific supply tunnels, gates, or channels for regulating NO entry to and nitrate efflux from the heme reaction center, a structure-sensitive electron transfer switch (38, 39, 40), an actuating lever to control the gates and switch, and an elastic torsion spring to store energy released by the NO dioxygenation reaction to drive and control motions. A lever and switch that together synchronize heme reduction with O2 and NO positioning, and thus prevent Fe2+NO formation, may explain the puzzling resistance of the NOD activity to irreversible NO inhibition, the observed reversible NO inhibition, and the higher-than-expected O2 dependence in the steady state (4, 5).

Results

O2 and NO dependence of flavoHb-NOD activity

The E. coli flavoHb-NOD activity (4), similar to other NOD activities (5, 10, 17, 21), shows parallel lines in inverse plots of velocity versus [NO] with varying [O2] (Fig. 1A) supporting a ping-pong mechanism. At higher NO concentrations, NO reversibly inhibits the activity, and NO inhibition appears competitive with respect to O2 with roughly 50% inhibition observed at a 1:100 ratio of NO to O2 as previously reported (45). O2 shows no competitive inhibition with respect to NO at O2:NO ratios exceeding 10,000:1. However, flavoHb shows less activity than expected with low [NO] and [O2] thus revealing activation by NO and O2. The activating effects of NO and O2 are more apparent at 20 °C (Fig. 1B). The data suggest a more complex ping-pong mechanism in which O2 and NO cooperatively activate NO dioxygenation.

Figure 1.

Figure 1

O2and NO dependence of the NOD activity.A, Lineweaver–Burk plots of WT NOD activity at 37 °C for various NO concentrations in the presence of 8 (◆), 30 (●), 90 (Δ), 200 (□), and 670 (O) μM O2. B, Lineweaver–Burk plots of the WT NOD activity at 20 °C for various NO concentrations at 8 (◆), 30 (●), 90 (Δ), 260 (▪), 670 (O), and 1140 (X) μM O2. Note the 6-fold y-axis scale difference between panels A and B. C and D, log–log plots of the data from panels A and B, respectively. The kinetic constants used to fit the kinetic model with the data (dashed lines) are given in Table 1.

Structural features and a proposed NOD mechanism

Structural dynamics may explain the cooperative activation of NODs by O2 and NO, the weak reversible competitive inhibition by NO, and the larger-than-expected requirements for O2. Similar to the M. tuberculosis HbN-NOD, the flavoHb-NOD appears to utilize a hydrophobic long tunnel (LT) for O2 entry (38), a hydrophobic short tunnel (ST) with an amphipathic entry for NO, and a gate for NO3 efflux (Fig. 2A). Six residues from the G and H helices form the outer wall of the ∼20-Å LT with three residues from the A helix and single residues from the B, E, and H helices forming the inner wall (Fig. 2B) (38). The passageway follows along the G-helix dipole in the positive direction. The side chains lining the LT are highly conserved among flavoHbs and single-domain Hbs (Table S1). Furthermore, the residues form a strictured or segmented tunnel with the capacity to hold up to three O2 molecules (38). The LT strictures show dimensions compatible with the passage of the nonpolar 3.2 Å by 4.3 Å van der Waals' dimension O2 molecule as previously demonstrated using molecular dynamics simulations with an estimated maximum energy barrier of 6 kcal/mol (38). However, although the static dimensions and clearances appear similar among the flavoHb and single domain Hb structures, it is noteworthy that the strictures differ with ligand states (Table S2). For example, with nitrite bound in the Saccharomyces cerevisiae structure (41) the clearance between the E15 and H12 residues is 3.1 Å wider and the restrictive distance between residues A16 and G16 is 1.6 Å greater, suggesting an active mechanism for controlling O2 movement during turnover. The LeuE11 side chain is in van der Waal's contact with the ferric iron in the E. coli flavoHb structure, thus apparently hindering O2 access to the iron, but LeuE11 does not form part of the LT.

Figure 2.

Figure 2

FlavoHb structural features and the NOD mechanism.A, E. coli NOD structure (Protein Data Bank [PDB] ID: 1GVH) (43) showing proposed pathways for O2 and NO entry and NO3 efflux. B, LT for O2 entry bounded by the G and H helices and traversing three strictures each formed by four side chains with the positions given. LT strictures and sites for O2 docking are labeled S3, S2, and S1. C, ST for NO entry with a narrow closed and a wide open gate (red arrows) as observed in the respective ferric E. coli NOD (PDB ID: 1GVH) (43) (top) and Fe3+NO2S. cerevisiae NOD (PDB ID: 4G1V) (41) (bottom) structures without bound water molecules. D, the proposed trigger mechanism for heme reduction in off and on states as seen in the respective ferric E. coli NOD (top) and Fe3+NO2S. cerevisiae NOD (bottom) structures. Residues 191 to 206 have been deleted from the foreground. The color code is Hb domain (beige or gray), reductase domain (yellow), heme (red or Corey, Pauling, Koltun [CPK] colors), iron (orange), FAD (green), water (aqua), and NO2 and side chains (CPK colors).

The putative ST shows a highly conserved outer entry defined by GlyG9, GlyH9, LeuG13, and TyrH12 (Table S3) and appears to be gated in the interior by ValG8-IleE15 and LeuE11–heme interactions (Fig. 2C, top). The S. cerevisiae ferric-nitrite enzyme structure shows a widening of the G8-E15 gate by 4 Å and a shift of the entire E-helix by ∼2 Å toward the putative NO entry site (compare red arrows in Fig. 2C, top and bottom, and Table S4). In the open state (bottom), LeuE11 is displaced toward the NO entry site to form a part of the ST interior presumably guiding NO for reaction with the bound Fe3+O2. By analogy to bound nitrite, O2 displacement of the LeuE11 may widen the gate for passage of the slightly polar 3.2 Å by 4.1 Å van der Waals' dimension NO molecule. The ST may have a capacity for more than one NO molecule.

The ferric E. coli flavoHb structure shows a CD loop in an unusual random coil with the GlnE2 side chain extended forming contact with the adenine ring of FAD in the reductase domain (Fig. 2D, top). A chloride ion is found bound in an anion hole in the E helix and CD loop corner (Fig. S1). Moreover, the ArgE3 guanidinium group, the E7 amide nitrogen, and a bound water bounding the anion hole show dimensions compatible with binding the trigonal planar nitrate anion in an E2-dependent efflux mechanism, whereas, with nitrite bound to the ferric heme in the S. cerevisiae flavoHb structure, the GlnE2 residue is found oriented inward with the D3-E4 segment in an energetically more stable alpha helix with the ArgE3 side chain oriented outward (Fig. 2D, bottom). Displacement of the LeuE11 side chain from the iron by nitrite, and presumably by nitrate, appears to twist the E-helix and exert a right-handed torsion to furl the CD loop (Fig. S1). In the unoccupied state, and presumably with nitrate release in the NOD mechanism, large phi torsion angle changes of ∼180° occur for the D4 and E3 residues in the conformers with the unfurled E2 and E3 carbonyl O-atoms interfering and repelling each other (Fig. S1), possibly storing mechanical energy from the NOD reaction, and providing spring-like right-handed elastic torque with refurling to assist LeuE11 displacement and E and F helix movements. Both CD loop types are also observed in the dimeric Ralstonia eutropha flavoHb-econazole structure (Fig. S2) (42) thus arguing for CD loop conformational changes rather than sequence-specific static structures.

The ferric E. coli and S. cerevisiae ferric-nitrite flavoHb structures also show differences in the positioning of the proximal LysF7 forming the bridge for electron transfer (ET) (39, 40), suggesting a switching mechanism that is activated by O2- and NO-leveraged motions. In the unoccupied ferric structure (Fig. 2D, top), the LysF7 epsilon ammonium group and GlnE7 amide oxygen atom hydrogen bond a water molecule near the middle of the ∼6-Å-long line-of-flight for ET between the heme carboxylate and FAD C8 methyl group (43) that is open to solvent exchange (38). In this model, the positioning of the electron-rich O atom of water hinders ET. The NO2 occupied structure shows a 10° torsional rotation of the F-helix relative to the heme plane (Fig. 2D, bottom) in which the GlnE7 amide is positioned with TyrB10 hydrogen bonding and stabilizing the Fe3+O2 intermediate and the LysF7 side chain positioned with the straight line-of-flight for ET passing 0.3 Å beyond the van der Waals' radius of the epsilon ammonium nitrogen, which presumably moves to the position of balance between repulsion by the core and attraction by the annular shell for optimal electron tunneling (44). Electron tunneling paths involving the bridging water molecule and LysF7 have been previously considered (2, 38, 39, 40). The structural differences suggest a LysF7-H2O-GlnE7 ET switch mechanism that is activated by the permeation of NO through the G8-E15 gate and by the further upward leveraging LeuE11 with a right-handed torsional twist of the E and F helices that is coupled to CD loop furling.

Reaction steps and a kinetic model

The structural features of flavoHb described above suggest a catalytic cycle, and testable kinetic model, to explain the cooperative O2 and NO activation observed in Figure 1, AB. In the kinetic model depicted in Figure 3, nonpolar O2 molecules are driven from the aqueous solvent into the LT with an equilibrium constant of K1, and the leading O2 displaces LeuE11 forcing the movement of the E-helix, docks with the ferric iron, the LeuE11 isobutyl group and the TyrB10 hydroxyl, and weakens the G8-E15 gate with an equilibrium constant of K2. NO then enters and passes through the ST further widening the G8-E15 gate with equilibrium constant K3 and leveraging the movement of LeuE11, the E-helix, GlnE7, the F-helix, and the LysF7 side chain while triggering furling of the CD loop with the first-order rate constant k'T and equilibrium constant (KT), ET (kET), and nitrate release (kp). Reduction of the ferric heme causes rapid univalent O2 reduction forming the Fe3+O2 intermediate, which then reacts rapidly with the internally sequestered NO with the bimolecular rate constant k'4 and equilibrium constant K4 forming the Fe3+NO3 intermediate that rapidly isomerizes (kis) (2, 6). Nitrate dissociates from the heme with the first-order rate constant kp, unfurls the CD loop, and migrates to the putative anion hole. In the proposed reaction scheme, NO inhibits by entering the LT and competing with O2 for the ferric heme as expressed by the Ki(NO) value. The model also allows for excessive NO to permeate a leaky NO entry gate, the nitrate efflux gate, or other pathways and inhibit catalysis with equilibrium constant Kii(NO). In the model, inhibitory NO binds ferric heme forming Fe2+NO+ (45), which readily dissociates (4) and resists reduction to Fe2+NO. The observed ET rate depends upon the LysF7-H2O-GlnE7 gate positioning and the FAD/FADH2 reduction potential, the driving force. The reaction scheme also shows pathways for O2 and H2O2 production as well as the motifs and residues most critical for each step.

Figure 3.

Figure 3

Reaction steps and kinetic constants in the NOD mechanism model. The equilibrium constants for the corresponding forward reactions are: K1, entry of O2 into the LT; K2, O2 displacement of LeuE11 and the shifting of the E-helix to widen the G8-E15 entry gate of the ST; K3, passage of NO through the narrow gate and the allosteric trigger point for structural changes allowing heme reduction (kET) and O2 ligation with an equilibrium constant of KT; and K4, reaction of NO with Fe3+O2 intermediate to form NO3. k'H, kET, kis, and kp are the rate constants for hydride transfer, electron transfer, peroxynitrite isomerization, and NO3 dissociation, respectively. Ki(NO) is the equilibrium constant for NO entering the LT and competitively inhibiting O2 migration and the displacement of LeuE11. Kii(NO) is the equilibrium constant for NO entry from the CD loop, ST, and other points causing uncompetitive inhibition. Curly brackets on O2 represent a localization to the distal heme pocket without electron sharing with the heme. Blue bars represent the tunnels and gates. The green box represents the flavoHb reductase domain.

We have formulated a steady-state velocity equation for the catalytic cycle with the activating trigger step (KT) (Equation 1).

v= Vmax(a) (1)

where a=([NO]2[O2]2/K1K2K3KTK4)/(1+([O2]/K1)+([O2]2/K1K2)+(([O2]2[NO])/K1K2K3)+(([O2]2[NO])/K1K2K3KT)+(([O2]2[NO]2)/K1K2K3KTK4))

We have also factored in NO acting as a competitive inhibitor with respect to O2 (Equation 2) (46).

v= Vmax(a)(b) (2)

where b=[NO]/(K3+([NO](1+((K2/[O2])(1+([NO]/Ki(NO)))))))

And, we have allowed NO and O2 to each act as uncompetitive inhibitors of catalysis (Equations 3 and 4, respectively).

v=Vmax (a)(b)(c) (3)

where = 1/(1+([NO]/Kii(NO)))

v=Vmax(a)(b)(c)(d) (4)

where = 1/(1+([O2]/Ki(O2)))

These additional independent statistical factors and the equilibrium constants Kii(NO) and Ki(O2) have been included for situations in which NO and O2 do not compete for LT or ST entry, or iron binding, but nevertheless inhibit catalysis. In addition, we have introduced a factor and equilibrium constant Ka(O2) for rare situations in which O2 causes an additional NO-independent activation of catalysis possibly by occupying unique binding sites or cavities (Equation 5). Equations (3), (4), (5) assume a normal hyperbolic binding and inhibition or activation response.

v=Vmax(a)(b)(c)(e) (5)

where e=1+([O2]/Ka(O2))

Fit of the mechanistic kinetic model with steady-state kinetic data

The kinetic data for the WT flavoHb in Figure 1, AB are transformed to the respective log–log plots in Figure 1, CD. Logarithmic plots were preferred since they display large ranges of substrate concentrations and velocities with a much greater resolution (46) and allow for same-scale visual comparisons. We have estimated the kinetic constants in Table 1 by fitting the velocity equation to the steady-state kinetic data with the resulting fits shown as dashed lines in Figure 1, CD. For fitting, we assumed K1 << K2. K1 was taken to be 2 μM, the value estimated from O2 association kinetics where Vmax/k'O2 was the theoretical Km(O2) of ∼2 μM at 20 °C (4). It should be noted that the theoretical v is most affected by the K1 value at low O2 and NO concentrations. When K1 is assigned a 10-fold larger value and K2 = 120 μM, v is <2-fold smaller with the largest effects at low [O2] and [NO]. And, smaller K1 values relative to a large K2 diminish any effects of K1 on v. A range of values for K3 and K4 were required to model the data at 20 °C as shown by the black and red dashed lines in Figure 1D and provided in the data in Table 1. A loss of harmonics and frustration in enzyme motion (47) may explain the deviations from a more ideal kinetic behavior at the subphysiological 20 °C. A k'NOD value of 1 to 2 × 1010 M−1 s−1 can be estimated from the Vmax/K4 ratio at 37 °C, a rate constant approaching the value of 6.9 × 1010 M−1 s−1 for the bimolecular reaction of NO and free O2 (48).

Table 1.

Kinetic constants for WT, and G8 and E11 variant flavoHb-NODs

Constant WT LeuG8 AlaG8 TrpE11 AlaE11
Vmaxa 580 (160) 650 (350) 550 (85–90) 500 (280) 300 (10–11)
K1b 2 (2) 2 (2) 2 (2) 2 (2) 2 (2)
K2b 120 (20) 200 (50) 80 (30) 400 (225) 100 (10)
K3b 0.25 (0.1–0.4) 0.9 (1.0) 0.1–0.2 (0.12–0.7) 12 (12) 0.04–0.15 (0.04–0.5)
KT 0.1 (0.1) 0.001 (0.01) 0.2 (0.2) 0.0001 (0.0001) 0.5 (1.5)
K4b 0.03–0.06 (0.06–0.3) 0.01–0.02 (0.03–0.07) 0.03–0.12 (0.03–0.10) 0.02–0.2 (0.01–0.25) 0.01–0.04 (0.01–0.03)
Ki(NO)b 0.7–1.2 (0.3–1.0) 0.4–20 (0.1–1.0) 0.15–1.0 (0.1–0.25) 0.2–3 (0.2–0.5) 0.4–10 (1–2)
Kii(NO)b 10 (10) 100 (100) 5 (10) 100 (3) 100 (3)
Ki(O2)b - - - - 300
- - - - -
Ka(O2)b - - - - -
- - - - (1000)
k'NOD appc 2.3 (0.4–1.6) 0.72 (0.35) 2.3–5.5 (0.12–0.75) 0.042 (0.023) 2.0–7.5 (0.02–0.28)
k'NODd 9.7–19 (0.5–2.7) 33–65 (5–12) 4.6–18 (0.9–3) 2.5–25 (1.1–28) 7.5–30 (0.3–1.1)

NOD, NO dioxygenase.

Values in parentheses are for 20 °C.

a

NO heme−1 s−1.

b

Micromolar.

c

Calculated from Vmax/K3 and expressed in units of 109 M−1 s−1.

d

Calculated from Vmax/K4 and expressed in units of 109 M−1 s−1.

Similar steady-state kinetic data for G8 and E11 substitution mutants are shown in Figures 4 and 5, respectively, and kinetic constants used to fit the data are also given in Table 1. Substituting ValG8 with the larger Leu residue increases K3, the apparent Km(NO), whereas substituting ValG8 with a smaller Ala decreases K3 as expected for a role for ValG8 in gating NO entry. The critical function of ValG8 in the allosteric mechanism is also suggested by the large changes in the KT values in the mutants, and the apparently large frustration of AlaG8 at 20 °C. The data also reveal a role for ValG8 in determining the susceptibility to NO inhibition. AlaG8 shows smaller Ki(NO) and Kii(NO) values, whereas the bulkier LeuG8 shows larger values. The effect is more discernible at 37 than 20 °C, again suggesting greater frustration at the lower temperature. A greater resistance of LeuG8 to NO inhibition also confers a higher Vmax at both temperatures; however, both the NO sensitivity, as indicated by small Ki(NO) and Kii(NO) values, and the impaired allosteric activation, as indicated by large KT values, lower the Vmax for AlaG8. The data support the roles for G8 shown in the kinetic model in Figure 3 and structure model in Figure 2C. G8 substitutions also cause relatively smaller effects on the O2 dependence (K2) suggesting effects on E-helix and LeuE11 movement.

Figure 4.

Figure 4

O2and NO dependence of G8 mutant NOD activities. Kinetic model calculations fitted to Lineweaver–Burk log–log plots of LeuG8 (A and B) and AlaG8 (C and D) NOD activities versus [NO] at 37 (A and C) and 20 °C (B and D). O2 concentrations were as described in the legend to Figure 1. Kinetic constants determined from the data and model are given in Table 1.

Figure 5.

Figure 5

O2and NO dependence of E11 mutant NOD activities. Kinetic model calculations fitted to Lineweaver–Burk log–log plots of TrpE11 (A and B) and AlaE11 (C and D) NOD activities versus [NO] at 37 (A and C) and 20 °C (B and D). O2 concentrations were as described in the legend to Figure. 1. Kinetic constants determined from the data and model are given in Table 1.

Substituting LeuE11 with the larger Trp caused large increases in K3 and K2 and a large decrease in KT (Table 1). Consistent with the structure-based kinetic model (Fig. 2C and Fig. 3), TrpE11 hinders NO access, increases the O2 requirement for activity, but nevertheless favors the activation by O2 and NO. In contrast, the smaller Ala substitution shows the opposite effects. Larger K2 values for the TrpE11 mutant indicate larger O2 requirements for displacement and E-helix movement. The small KT suggests a strong, and effective, response to NO movements. The data support roles for LeuE11 as the O2 and NO activated trigger for the allosteric mechanism and as a part of the NO access tunnel. However, the data for the AlaE11 variant were unusual in that the kinetic model could only be fitted to the data by allowing for O2 inhibition at 37 °C and O2 activation at 20 °C.

GlnE2 within the CD loop was tested for its proposed role in the allosteric mechanism. Data for E2 substitution flavoHbs are shown in Figure 6, and kinetic constants used to fit the data are given in Table 2. Substitution of the highly conserved GlnE2 with Asn, Leu, His, and Glu causes larger KT values representing an impaired activation of ET by NO and O2, thus producing a two- to threefold decrease in the Vmax values and proportionally smaller K3 and K4 values. K2 values increase two- to threefold except for the His substitution at 37 °C. The data demonstrate an important role for GlnE2 in the NOD mechanism. The larger Vmax values and lesser effects of oppositely charged His and Glu substitutions on KT suggest that Gln allows optimal furling–unfurling of the CD loop rather than interacting directly with nitrate. Furthermore, the consistently smaller Kii(NO) values of the E2 variants suggest a CD loop structure dysfunction that opens a migration pathway for NO.

Figure 6.

Figure 6

O2and NO dependence of E2 mutant NOD activities. Kinetic model calculations fitted to Lineweaver–Burk log–log plots of E2 substitution NOD activities versus [NO] at 37 (top panels) and 20 °C (bottom panels). O2 concentrations were as described in the legend to Figure 1. Kinetic constants determined from the data and model fitting are given in Table 2.

Table 2.

Kinetic constants for E2 flavoHb-NOD variants

Constant AsnE2 LeuE2 HisE2 GluE2
Vmaxa 135 (50) 155 (60) 225 (115) 250 (90)
K1b 2 (2) 2 (2) 2 (2) 2 (2)
K2b 300 (70) 275 (60) 120 (70) 350 (70)
K3b 0.015–0.07 (0.05–0.08) 0.05–0.08 (0.15–0.2) 0.10–0.15 (0.13–0.5) 0.05–0.15 (0.07–0.3)
KT 2.0 (2.0) 1.5 (2.0) 0.7 (0.7) 0.7 (1.0)
K4b 0.01 (0.01–0.05) 0.01–0.03 (0.03) 0.03–0.04 (0.03–0.05) 0.02–0.03 (0.03–0.07)
Ki(NO)b 1–10 (0.5–2) 3–10 (0.35–0.6) 0.7–2 (0.5–2) 0.8–5 (0.3–2)
Kii(NO)b 10 (3) 2 (3) 3 (3) 10 (3)
k'NOD appc 1.9–9 (0.63–1.0) 1.9–3.1 (0.3–0.4) 1.5–2.3 (0.45–1.7) 1.7–5 (0.3–1.3)
k'NODd 13.5 (1.0–5.0) 5.2–15.5 (2.0) 5.6–7.5 (2.3–3.8) 8.3–12.5 (1.3–3.0)

NOD, NO dioxygenase.

Values in parentheses are for 20 °C.

a

NO heme−1 s−1.

b

Micromolar.

c

Calculated from Vmax/K3 and expressed in units of 109 M−1 s−1.

d

Calculated from Vmax/K4 and expressed in units of 109 M−1 s−1.

TyrB10 and GlnE7 are important for stabilization of the Fe3+O2 intermediate in (flavo)Hbs (1, 4, 49). In the proposed kinetic model (Fig. 3), mutants with decreased Fe3+O2 stability and larger O2 dissociation rate constants are expected to show a higher O2 dependence and larger K2 values, a greater competitiveness of NO for Fe3+, and potentially Fe2+, and smaller Ki(NO) and Kii(NO) values, and an inefficiency of NO dioxygenation and larger K4 values. In addition, GlnE7 mutants are expected to show impaired ET switching and altered kET and KT values. Data for B10 and E7 flavoHb variants measured at 20 °C are shown in Figure 7, and kinetic constants used to fit the data are given in Table 3. Indeed, the mutant NODs are highly susceptible to NO inhibition and show small Ki(NO) and Kii(NO) values, which also limited the O2 and NO concentrations as well as the temperature that could be tested. PheB10 shows a 4-fold larger K2 value while LeuE7 and HisE7 show more modest two- to threefold increases. HisE7 shows a larger KT value possibly reflecting impaired ET while LeuE7 shows negligible effect on the KT value suggesting normal switching at 20 °C, but not 37 °C. K3 values are unexpectedly increased in the PheB10 and E7 mutant NODs and may reflect a role for TyrB10 and GlnE7 in facilitating O2 binding and the displacement of LeuE11 from the ferric iron. Of interest, the calculated Vmax values are not decreased in the mutants indicating the capacity of elevated O2 concentrations to overcome any defects in O2 binding and Fe3+O2 stabilization. The greater susceptibility to NO inhibition at a higher [NO], a lower [O2], and 37 °C may be explained by Fe2+NO formation.

Figure 7.

Figure 7

O2and NO dependence of B10 and E7 mutant NOD activities. Kinetic model calculations fitted to log–log Lineweaver–Burk plots of PheB10 (A), LeuE7 (B), and HisE7 (C) NOD activities versus [NO] at 20 °C. O2 concentrations were as described in the legend to Figure 1. Kinetic constants determined from the data and model fitting are given in Table 3.

Table 3.

Kinetic constants for the B10 and E7 flavoHb-NOD variants

Constant PheB10 LeuE7 HisE7
Vmaxa 180 250 200
K1b 2 2 2
K2b 400 45 60
K3b 1.0–1.5 0.7–1.3 0.3–0.9
KT 0.1 0.1 0.5
K4b 0.10–0.12 0.1 0.10–0.12
Ki(NO)b 0.06–0.12 0.05–0.6 0.006–0.017
Kii(NO)b 0.2 0.5 0.5
k'NOD appc 0.12–0.18 0.19–0.35 0.22–0.67
k'NODd 1.5–1.8 2.5 1.7–2.0

NOD, NO dioxygenase.

All values are for 20 °C.

a

NO heme−1 s−1.

b

Micromolar.

c

Calculated from Vmax/K3 and expressed in units of 109 M−1 s−1.

d

Calculated from Vmax/K4 and expressed in units of 109 M−1 s−1.

In the kinetic model (Fig. 3), the velocity (v) also serves as a measure of the rate of ET as expressed as a first-order time-averaged rate constant for ET, and the minimal kET value (4, 5). Furthermore, changes in the NADH dependence of the velocities of variant NODs reveal alterations in the ET gating efficiency, where the v approximates the kET value owing to the gating mechanism, provided that hydride transfer, and the k'H value, remains constant for FAD reduction (Fig. 3). Thus, [NADH]k'H determines the steady-state FAD/FADH2 ratio, and the reduction potential that directly influences the ET rate through a tunneling matrix (44), and the absolute kET value. In the steady state, Δv/Δ[NADH] values thus provide a sensitive, albeit indirect, measure of the putative LysF7-H2O-GlnE7 ET gate function during catalysis (Fig. 2D) where a smaller Δv/Δ[NADH] value indicates a decreased rate of ET, an inefficient tunneling matrix, and dysfunctional gating mechanism. As shown in Figure 8, the TrpE11 mutant, all E2 substitutions, and the HisE7 mutant show increased slopes in 1/v versus 1/[NADH] plots at 37 and 20 °C and smaller Δv/Δ[NADH] values (Table 4). In addition, the AlaE11 substitution shows an increased slope and smaller Δv/Δ[NADH] value at 20 °C. Dysfunction of ET in the TrpE11, LeuE2, LeuE7, and HisE7 substitutions is observed at 37 °C, and even greater effects of all E11 and E2 substitutions and the HisE7 substitution are observed at 20 °C. LeuE7 shows a small stimulatory effect at 20 °C compared with GlnE7. The G8 substitutions show only minor effects, and those are observed at 20 °C with Ala decreasing and Leu increasing the efficiency. The PheB10 substitution also shows only minor effects.

Figure 8.

Figure 8

Effects of G8, E11, E2, B10, and E7 substitutions on the NADH dependence of the NOD activities. Lineweaver–Burk plots of NOD activities with varying NADH at 37 (A, C, and E) and 20 °C (B, D, and F). Dashed lines (CD) represent WT data (AB).

Table 4.

NADH dependence of WT and mutant NODs

NOD Δv/Δ[NADH] (s-1 μM-1)
WT 59 (36)
LeuG8 60 (44)
AlaG8 60 (31)
TrpE11 26 (12)
AlaE11 53 (13)
AsnE2 24 (10)
LeuE2 14 (10)
GluE2 24 (14)
HisE2 23 (14)
WTa 59 (30)
PheB10a 44 (33)
LeuE7a 32 (33)
HisE7a 6.4 (7.1)

NOD, NO dioxygenase.

a

Values are for 130 nM NO. Values in parentheses are for 20 °C.

The results demonstrate roles for GlnE7, LeuE11, and GlnE2 in ET consistent with the proposed mechanism and kinetic model. The analysis also indicates that higher NADH concentrations, and thus more negative flavin redox potentials, can drive catalysis and ET in a defective gate mechanism. The low-temperature dependence of Δv/Δ[NADH] also indicates a relatively low energy barrier for the hydride and electron transfer steps.

Kinetics of hydride and ET

As previously reported (4), NADH reduces FAD to FADH2 with a large bimolecular rate constant for hydride transfer (k′H) of 1.5 × 107 M−1 s−1 as detected by the transient decrease in FAD absorbance at 460 nm (Fig. 9A, line 1). Similar FAD reduction rates are observed for the PheB10, LeuE7, and HisE7 variants (lines 2–4, respectively) with the HisE7 mutant showing a greater extent of FAD reduction. FADH2 rapidly reduces the WT flavoHb ferric heme to the ferrous state with a maximum kET value of 120 s−1 at 20 °C as measured by the transient increase in absorbance at 430 nm (Fig. 9B, line 1), similar to the 136 s−1 value previously reported (4). In comparison, the apparent kET values for the PheB10, LeuE7 and HisE7 variants are 160, 140 and a biphasic 1.7 s−1 or 50 s−1, respectively (lines 2–4). It is noteworthy that the HisE7 variant showed a biphasic behavior with an initial slow reduction followed by a more rapid phase with incomplete reduction (line 4) despite achieving a more negative FAD/FADH2 reduction potential (Fig. 9A, line 4). The HisE7 variant appears to favor the off conformation (see Discussion). In contrast, WT, LeuE7, and PheB10 flavoHbs appear to favor an on conformation in the resting state. Both the k′H and kET values of the WT, LeuE7, and PheB10 flavoHbs are within the range of values required to support the NOD turnover rates measured at 20 °C (Tables 1 and 3). The transient kinetic data further support a role for GlnE7 movements in the ET gate function. ET rates, and kET values, depend upon the resting-state structure and the FAD/FADH2 potential.

Figure 9.

Figure 9

Kinetics of the reduction steps in WT, and B10 and E7 substitution mutants.A, FAD reduction and oxidation as measured by the absorbance changes at 460 nm and B, heme reduction as detected by the increase in absorbance at 430 nm for the WT (line 1), PheB10 (line 2), LeuE7 (line 3), and HisE7 (line 4) flavoHbs.

O2, NO, and CO binding

The kinetic model predicts specificity and dynamic changes in ligand migration pathways during catalysis. Indeed, a heterogeneity in ligand migration pathways was evident in previous biphasic ligand binding kinetics (4, 5). However, biphasic kinetics was attributed to a structural heterogeneity in the isolated flavoHbs, rather than to the existence of multiple and dynamic pathways, as recently argued for CO migration in Cygb (50).

A critical reanalysis of the ligand binding kinetics of flavoHb shows evidence of dynamic changes and multiple pathways. Following the high-energy laser photolysis perturbation, flavoHb rebinds O2, NO, and CO with biphasic kinetics (Fig. S3) with transition times (τT) for the fast and slow phases in the 10- to 200-μs range (Table 5). For O2 rebinding to the WT flavoHb, the τT is ∼55 μs for both high and low [O2] conditions, while the fraction of flavoHbFe3+O2 formed in the fast phase decreases by ∼50% with lower [O2] (Fig. S4). These data demonstrate a relatively slow, but large, loss in pathways available for O2 migration and rebinding following the photolytic perturbation. Moreover, the slow phase of O2 (1 mM) rebinding is 86% inhibited by 100 μM CO, whereas the fast phase is only inhibited by ∼10%, (Table 5, Tables 5 and S5) indicating that the relevant migration pathway(s) for the NO dioxygenation mechanism are represented by the slow phase since CO competitively and potently inhibits the NOD activity with respect to O2 (5), and presumably inhibits O2 migration through the LT as well as O2 binding to the iron. The PheB10 and HisE7 variants show similar k'slow (O2) values, but show only ∼50% inhibition of O2 migration and binding by CO in the slow phase suggesting availability of pathways for O2 migration, such as the ST, CD loop, or E-helix heme interface, in addition to the LT. The mutations, iron redox state, ligand types, and concentration affect the τT for ligand binding and the photolysis fraction (Φdis) in ways that are not readily interpretable. We suppose that the large τT values of >8 μs are due to gases transiently maintaining nonspecific pathways for gas migration initially opened by the quake of photolysis (see Discussion).

Table 5.

Kinetic constants for ligand binding to flavoHb-NODs

Ligand pair Φdis
k′fast
τT
k′slow
k
Kd
% μM−1 s−1 μs μM−1 s−1 s−1 nM
Fe2+ O2
 WT 1.6 33 (90%) 70 ± 5 14 (10%) 0.20 14
 PheB10 4.9 180 (79%) 20 ± 10 13 (21%) 3.5a 269
 LeuE7 3.0 28 (85%) 100 ± 20 16 (15%) 1.4 88
 HisE7 0.9 75 (60%) 10 ± 5 12 (40%) 5.8 483
Fe2+ NO
 WT 4.4 31 (57%) 40 ± 10 8.5 (43%) 0.0002 (4) 0.024
 PheB10 2.4 145 (78%) 8 25 (22%) 0.0001 (4) 0.004
 LeuE7 2.4 191 (59%) 8 39 (41%) n.d.
 HisE7 2.0 45 (53%) 8 ± 3 12 (47%) n.d.
Fe3+ NO
 WT 22 46 (57%) 18 ± 3 12 (43%) ∼4000 (4) 3.3 × 105
 PheB10 21 64 (58%) 18 ± 3 13 (42%) n.d.
 LeuE7 16 72 (63%) 13 ± 3 13 (37%) n.d.
 HisE7 16 70 (61%) 13 ± 8 7.5 (39%) n.d.
Fe2+ CO
 WT 13 14 (72%) 175 ± 25 1.4 (28%) 0.055 (32%) 12–39
0.017 (65%)
 PheB10 15 67 (65%) 75 ± 25 3.0 (35%) 0.029 (29%) 1.3–9.7
0.004 (71%)
 LeuE7 11 5.8 (77%) 150 ± 50 1.0 (23%) 0.076 (13%) 16–76
0.016 (87%)
 HisE7 15 15 (44%) 10 ± 5 1.2 (56%) 0.058 (35%) 1.0–48
0.015 (65%)

NOD, NO dioxygenase.

a

Smaller than previously reported (4) because the previous value (34 s−1) contained an error owing to CO binding to the deoxy form. n.d. indicates values not determined.

Slow phases of ligand binding were accordingly used for the revised calculations of Kd values and for analyzing the enzyme mechanism. PheB10, LeuE7, and HisE7 substitutions show similar k′slow (O2) values, but show larger k(O2) values, and respective 19-, 6-, and 35-fold larger Kd(O2) values than the WT enzyme (Table 5). The results further support roles for a TyrB10 and GlnE7 hydrogen bond network in stabilizing the Fe3+O2 intermediate (1, 49), and together with the kinetic model in Figure 3, help to explain the steady-state kinetic data in Figure 7 and Table 3. Moreover, the 29-fold larger k(O2) value measured for the HisE7 variant relative to that for GlnE7 (Table 5) further suggests that the HisE7 variant, in its resting state, favors the off conformation with positively charged HisE7 in proximity to the negatively charged heme propionate as modeled for GlnE7 in Figure 2D (top). In addition, the comparable k′slow (NO) and k′slow (O2) values and the large k(NO) values for the ferric flavoHbs (Table 5) may account, in part, for the reversible NO inhibition reported in Figure 1 and modeled in Figure 3. Conversely, comparable k′slow values for O2 and NO and extremely small k(NO) and Kd(NO) values for the ferrous flavoHb (Table 5), and an absence of irreversible NO inhibition, largely preclude the previously suggested ping-pong mechanism (3, 4). Applying the k(NO) values, we can calculate 90% activity recovery following NO binding in 3.2 h for the ferrous NO species and a mere 0.6 ms for the ferric NO form. With NO elimination via reduction (≤0.1 s−1) (4, 5), 90% reversal in the steady state would require 23 s. However, NO inhibition is competitive with O2 and seamlessly transient under the steady-state conditions of Figures 1 and Figure 4, Figure 5, Figure 6, Figure 7 indicating a predominant competition for the LT entry and ferric iron as modeled in Figure 3. NO and O2 show remarkably similar k′slow values for Fe3+ and Fe2+, respectively, suggesting a similar entry and migration through the LT and interactions with LeuE11.

Role of LysF7 in ET control

LysF7 was investigated for its role in gating ET with an AsnF7 substitution that removes the proposed toggling epsilon ammonium group in the gate structure (Fig. 2D). The starting activity of the AsnF7 enzyme is 6-fold less than the LysF7 (WT) enzyme and rapidly inactivated. Ninety percent of the starting activity is lost in less than 1000 turnovers or ∼30 s (Fig. 10A, compare line 1 with line 2). In the absence of NO, the AsnF7 enzyme loses 85% of its NOD activity in 90 s with apparent zero order kinetics (Fig. 10B, line 1). Thus, NO is not essential for the inactivation, but NO greatly increases the inactivation. Catalase provides modest protection (Fig. 10B, compare lines 1 and 2) suggesting formation of Fe3+-OOH, and H2O2, and oxidative damage to the heme. Indeed, flavoHb-NOD activity is sensitive to H2O2, and the heme ligand miconazole (51) and the peroxidase substrate ascorbate both protect in the resting state (Fig. S5). The AsnF7 variant shows other indications of changes in ET fidelity or control including a 2.8-fold greater NADH oxidase activity (0.76 versus 0.27 s−1), a 2.4-fold greater NO reductase activity (0.45 versus 0.19 s−1), a fourfold higher methyl viologen reductase activity (1.45 versus 0.36 s−1), a 4.6-fold higher cytochrome b5 reductase activity (0.65 versus 0.14 s−1), a 4.5-fold higher Ngb reductase activity (0.90 versus 0.20 s−1), and a twofold higher trimethylamine-N-oxide (TMAO) reductase activity (0.41 versus 0.21 s−1). CO (50 μM) inhibits TMAO reduction by ∼90% suggesting an increased ET and reduction by the heme. Other reductase activities are relatively resistant to 50 μM CO. Increased rates of reduction demonstrate an increased ET from the flavin and a loss of the electron tunneling path directionality (44) and coupling control in the mutant.

Figure 10.

Figure 10

Autocatalytic inactivation of an AsnF7 substitution mutant NOD.A, NOD activities of AsnF7 (line 1) and LysF7 (line 2) flavoHbs were followed at 37 °C with 200 μM O2 with between 1 and 2 μM NO, and B, activity was measured at various times in the absence (line 1) or presence of 1000 U of catalase (line 2).

Together these data support a role for the conserved LysF7 epsilon ammonium group in forming part of a switchable gate, or dynamic matrix, for ET that controls the rate, timing, and tunneling pathway for ET. Mistiming of heme reduction may also cause irreversible NO inhibition and a rapid inactivation; i.e., a mistiming of ET creates the opportunity for NO to bind Fe2+ irreversibly during turnover.

Discussion

Cooperative activation of the NOD function of the E. coli flavoHb by the substrates O2 and NO is explained by motions of the protein triggered by the gases and the product nitrate. Motions, although not directly observed, are inferred from the available x-ray crystal structures and from the effects of conserved amino acid substitutions on the steady-state and transient kinetics. Deficiencies and paradoxes of the rudimentary ping-pong model (3, 4) are resolved by an allosterically controlled ping-pong mechanism in which ET is activated by O2 and NO positioning (Fig. 3). A critical reevaluation of NADH-driven enzyme velocities (Table 4) and heme reduction rates demonstrates activation of ET by O2 and NO. Comparable changes in the rates of heme reduction in the absence of O2 and NO require approximately fourfold greater NADH concentrations (4), and thus more negative flavin redox potentials and a greater driving force. Furthermore, ET transfer rates measured by stopped flow (Fig. 9) reveal on and off states in resting state structures representative of steps in the dynamic switching mechanism. From the data in Table 1, Table 2, Table 3, Table 4, we can begin to estimate times and activation energies for the steps in catalysis and compute the effects of various mutations. For example, from the Vmax values, we can calculate that the rate-limiting step of the WT enzyme requires 1.7 and 6.3 ms at 37 and 20 °C, respectively. The near diffusion-limited Vmax/K3 value of 2.3 × 109 M−1 s−1 and the four- to eightfold larger Vmax/K4 value at 37 °C indicates that multiple NO collisions and the wiggling of G8, E15, E11 side chains within the ST are required for, and limit, ET activation and the NOD reaction. Applying the Arrhenius equation for Vmax at the two temperatures, we can approximate an overall activation energy (Ea) equal to 13.7 kcal/mol, an amount equivalent to that required to break three to four hydrogen bonds. The largest effect on the Ea is observed with the AlaE11 substitution with a calculated Ea of 24.6 kcal/mol and a 5- to 15-fold larger temperature-dependent KT value further suggesting that LeuE11 movements due to NO collisions, and concerted motions of the CD loop, E and F-helices, and LysF7, form the largest energetic barrier, and also the rate-limiting step in the NOD mechanism. Following this analysis, we can also see that the forward rate constant for the trigger and switching mechanism, k′T, limits and equals the Vmax value.

ET in flavoHb (kET), on the other hand, has been reported to be ∼40-fold faster by time-resolved pulse radiolysis (6800 s−1) (39) than the maximal NADH-driven ET rate measured by stopped flow (160 s−1) (Fig. 9B) (4) indicating that ET per se is not rate limiting and suggesting experimental differences in the matrix, transfer distance, or FAD/FADH2 potential (E0 = < −0.15 V) (52). Furthermore, the HisE7 substitution may impair ET in the steady state (Fig. 8 and Table 4) and resting state (Fig. 9B, line 4) by strengthening bonding to the heme propionate in the ET gate structure and stabilizing the off state (Fig. 2D, top) and, moreover, by significantly decreasing the nominal −0.125 V heme mid-point potential (52). The E7 position is too distant for the histidine to coordinate with the iron. Nevertheless, the structures (Fig. 2C) together with spectral analysis (unpublished results) suggest a relaxed to tense motion in the heme corresponding to a high spin (S = 5/2) to low spin (S = 1/2) ferric iron transition (53) with a large calculable heme mid-point potential drop of ∼0.09 V that may account for decreased extents of heme reduction despite lower FAD/FADH2 potentials and a greater driving force (Fig. 9B). Furthermore, thermally fluctuating spin state mixtures in the resting state may account for the observed intermediate ET rates (Fig. 9B). Accordingly, the proposed conformational changes of the F-helix in the trigger step (KT) force a low to high spin transition and associated potential increase, besides switching the ET gate on (Figs. 2D and 3). Although matrix perturbations in outer sphere ET processes, as modeled for flavoHb in an on state (Fig. 2D, bottom) (38, 39), show greater effects on kET values than small differences in ΔE0 values with generally large 1-V reorganization energies (44), corrections to the nominal heme mid-point potential due to a mixed resting ferric iron spin state will also influence kET values following the Marcus electron-transfer equation (38, 39, 44).

The free energy released in the reaction of NO and O2 forming peroxynitrite is 29 kcal/mol (54), and the reaction of NO with MbFe3+O2 to form nitrate releases more than 30 kcal/mol (55). The Mb-catalyzed isomerization of peroxynitrite to nitrate occurs in the submillisecond time range (6, 56) indicating that kis would not be rate limiting. In the model (Fig. 3), NO3 release (kp) and efflux are coupled with CD loop unfurling–furling, and the rate constants thus equal Vmax. We suppose that the initial step in the exergonic NO dioxygenation reaction, as represented by k'4, where k'4 equals Vmax/K4 and k'NOD, ultimately provides the energy required to drive protein motions and support the catalytic cycle. Furthermore, by analogy, a 577-nm photon, bearing 49.6 kcal/mol, and absorbed by the flavoHb during photolysis of O2 or other bound ligands, would suffice to trigger large protein motions via LeuE11, TyrB10, and GlnE7 interactions and contribute to the microsecond-scale heterogeneity of ligand migration evidenced by the data in Table 5, Tables 5 and S5; and Figs. S3 and S4, and elsewhere (4, 5). In the photolysis of MbFe2+CO, most motion occurs in the nanosecond range, but CO-induced structural changes and hydration shell fluctuations, nevertheless, continue for microseconds (57, 58, 59, 60).

In the model, K2, not K1, and the apparent Km(O2) is only roughly approximated by Vmax/k'slow (O2). K1 may also be further broken down to movement of O2 through the strictures between the docking sites S3, S2, and S1 with a relatively large 6 kcal/mol energy barrier estimated for the narrow stricture 2 controlling passage from S2 to S1 (38). Displacement of LeuE11 by nitrite, and presumably nitrate also, widens the clearance of A16-G16 in stricture 2 by 1.6 Å, and the clearance of E15-H12 in stricture 1 by 3.1 Å (Table S2). Indeed, the Ki(NO) values of 0.3 to 1.2 μM determined for NO competition with O2 for LT entry (Table 1), and also comparable Ki(CO) values of ∼1 μM (5), argue for the relatively small K1 value of 2 μM applied throughout in modeling the kinetics, and a facile entry and passage of O2. Variations in the number of O2 molecules in the LT with [O2] may explain the two- to threefold range in Ki(NO) values estimated for the WT flavoHb.

A surprising outcome or prediction of the allosteric model is that a paramagnetic O2 molecule, with an induced dipole, interacts magnetically with the paramagnetic ferric iron atom in displacing LeuE11 and, moreover, that TyrB10 and GlnE7, as well as the G-helix dipole, affect this interaction. Indeed, the Fe3+ and O2 interactions are relatively weak given the large micromolar K2 values (Tables 1 and 3) relative to the corresponding nanomolar Kd values for Fe2+O2 (Table 5). The strictured and segmented LT further suggests potential mechanisms for the controlled storage and influx of O2 in the NOD function of flavoHb and roles for similar tunnels in other globin-NODs including HbN, the alpha subunit of HbA (1861), and Cygb (10, 17, 36, 37, 50). The failure of O2 to compete with NO suggests strong discrimination against O2 entry by the ST. In the S. cerevisiae flavoHb ferric-nitrite structure, water molecules hydrogen bonded to GlyH9 and ProG6 peptide carbonyls guard the ST entryway. Nonpolar O2 does not readily penetrate hydration shells on protein surfaces (62), and some protein sites bind water more tightly than others (63). Polar NO may displace the polar water molecule(s) and enter, whereas O2 may not. In the case of thermoglobin (64) (Table S3), a putative NOD, the unique charged LysG9 and GluH9 pair may better serve the NO gating function at the hydrogen bond–breaking 95 °C of the archebacterial existence. The failure of ubiquitous and abundant N2, the carrier gas, to compete with O2 for LT entry and inhibit the NOD function also requires explanation. The greater than 80-fold selectivity for O2 over N2 apparent in the steady-state data (Fig. 1A) may be achieved by a discriminator for the inducible lateral O2 dipole. The diametric PheG20 phenyl group and ThrA12 O-atoms within stricture 3 (Fig. 2B and Table S1) may serve this function by conjugating and repelling π∗/π molecular orbitals thus allowing O2 passage, but excluding entry of the less polarizable N2 molecule.

The model also predicts that motions in the LysE7 epsilon ammonium group, triggered by NO motions and passage by the LeuE11 barrier in the ST, ultimately control the on and off states and tunneling path for ET, and, furthermore, that GlnE7 and GlnE2 movements participate in the switching mechanism as evidenced by the strong inhibitory effect of the HisE7 and E2 substitutions on ET (Table 4 and Figs. 8 and 9B). We suppose that a small KT value, and a strong trigger, will favor the on position and that larger KT values, like that shown by the HisE7 variant, will favor the off position in the resting state. Further exploration of the effects of mutations, and tunneling matrix modifiers or dopants, on ET rates in flavoHbs should be illuminating provided that the fine structure of the switch mechanism can be mirrored, and the FAD/FADH2 potential controlled, in the resting state(s). Furthermore, the model and Fig. S1 suggest that NO3, instead of chloride, normally binds and stabilizes the unfurled off configuration of the CD loop. Moreover, CD loop furling–unfurling may play an unrecognized role in the channeling of nitrate by ThrE2 in HbN-NOD (34) and the channeling of other anions (65, 66) by various globins.

The data and model can also be used to determine the physiological limits of the allosteric NOD mechanism. The data in Figure 1C demonstrate kinetics consistent with the mechanism at a physiologically relevant 8 μM O2 with a velocity of 8 s−1 at 2 μM NO. Applying Equation 3 and the constants in Table 1, we can calculate that at 0.4 μM O2 and 1 μM NO, the velocity of the allosteric NOD activity approximates the Vmax of 0.1 s−1 for Fe2+NO reduction (4, 5). A similar comparative analysis can be done to evaluate the functional significance of the bimolecular reaction of O2 with Fe2+NO/Fe3+NO (11), but the dependence of the reaction on [O2], and a small rate constant, make the reaction inconsequential (2). Consistent with this analysis, flavoHb fully protects E. coli growth under an atmosphere containing 5 μM O2 and 0.5 μM NO (67) and shows insignificant NO metabolic activity in anaerobic E. coli (68).

Finally, the aggregate data and model suggest that all globins functioning as NODs have evolved allosteric mechanisms for controlling gas movements (69), timing ET (10), expelling nitrate, and averting irreversible NO inhibition and a reductive inactivation. Further investigations of ET in flavoHb promise to increase our understanding of conformationally gated ET, the NOD mechanism of globins, and the evolutionary origins of the relaxed-tense heme transitions for allosteric cooperativity in O2 binding by O2-transporting Hbs (53).

Experimental procedures

Reagents

Reagents were purchased from Sigma-Aldrich Chemical Co (St Louis, MO, USA) unless otherwise stated. DNA primers were synthesized at the University of Cincinnati Medical Center DNA facility. Praxair (Bethlehem, PA, USA) was the supplier of 99.993% O2, 99.999% CO, and 99.98% N2. Bovine liver catalase (260,000 U/ml) was obtained from Roche Applied Science. Recombinant rat cytochrome b5 (soluble form) and murine Ngb were expressed in E. coli and purified essentially as described (10, 70). NADH purity (≥95%) was assessed by the ratio of the 340 to 260 nm absorbance with a value of 0.437 equal to 100% reduced.

Construction of FlavoHb variants

pUC19hmp was constructed by ligating the EcoR1-BamH1 fragment from pAlterhmp (4) into pUC19 (71). Substitution mutants were constructed using the Altered Sites II mutagenesis system (Promega) with pAlterhmp as the template and the corresponding sense primers with codon changes shown in bold face type:

LeuG8, 5′-CAGTACAACATCCTCGGTGAACACCTG-3′;

AlaG8, 5′-CAGTACAACATCGCCGGTGAACACCTG-3′;

TrpE11, 5′-GATCAACGTGAAGCCTGGTTTAACGCTATTGCC-3′;

AlaE11, 5′-GATCAACGTGAAGCCGCGTTTAACGCTATTGCC-3′;

AsnE2, 5′-TTTAACATGAGTAACAATCGTAATGGCGATCAA-3′;

LeuE2, 5′-TTTAACATGAGTAACCTGCGTAATGGCGATCAA-3′;

HisE2, 5′-TTTAACATGAGTAACCATCGTAATGGCGATCAA-3′;

GluE2, 5′-TTTAACATGAGTAACGAGCGTAATGGCGATCAA-3′;

PheB10, 5′-CGCCCATTTCTTCGACCGTATGTT-3′;

LeuE7, 5′-GTAATGGCGATCTACGTGAAGCCC-3′;

GluE7, 5′-CGTAATGGCGATGAACGTGAAGCC-3′;

HisE7, 5′-TAATGGCGATCACCGTGAAGCCCTG-3′;

AsnF7 was constructed by PCR mutagenesis using pUC19hmp as the template with the sense primer 5′-CGGTAGAAAAAATCGCGCAGAATCACACCAGCTT-3′ and the antisense primer 5′-CTGCGCGATTTTTTCTACCGCTGGCAGCAG-3′. All constructs were verified by DNA sequencing, and agarose gel purified NdeI-BamHI fragments of the pAlterNOD variant constructs were ligated into the NdeI-BamHI digested pUC19hmp. Engineered pUC19NOD variant constructs were transferred to the hmp deletion strain AG103 (68) for expression.

Expression and purification of NODs

Cultures of AG103 bearing pUC19hmp, and engineered variants thereof, were grown microaerobically in a phosphate-buffered medium containing yeast extract, tryptone, glucose, nitrate, hemin, and ampicillin and were harvested, purified, and analyzed as previously described (4). Batches of 1-l cultures were grown microaerobically in 2-l flasks by a slow gyrorotatory motion and were harvested after 16 h. Isolated flavoHbs contained between 0.6 and 0.9 mol fraction of heme and between 0.3 and 0.9 mol fraction of FAD. FlavoHbs were reconstituted with heme and FAD (4,72).

Assay of NOD and other flavoHb activities

NOD activity was measured amperometrically in 100 mM phosphate buffer, pH 7.0, containing 0.3 mM EDTA, 100 μg/ml bovine serum albumin (BSA) (Fraction V), 100 μM NADH, 0.1 μM FAD with NO, O2, and N2 mixtures added as described (4, 72). NADH oxidase activity was followed spectrophotometrically at 340 nm in a 1.0-ml cuvette containing 90 mM Tris chloride buffer, pH 8.2, 100 μM NADH, 200 μM O2, 0.1 μM FAD, 100 μg/ml BSA, and 0.3 mM EDTA and incubated at 37 °C. Cytochrome b5 reductase activity was assayed at 37 °C by following the rate of absorbance increase at 555 nm in a 1.0-ml reaction buffered with 90 mM Tris chloride, pH 8.2, and containing 10 μM ferric cytochrome b5, 200 μM O2, 20 μM NADH, 0.1 μM FAD, 100 μg/ml BSA, and 0.3 mM EDTA. TMAO reductase activity was assayed by following the absorbance decrease at 340 nm in a 1.0-ml anaerobic reaction containing 12 U Aspergillus niger glucose oxidase, 5 mM glucose, 260 U catalase, 400 mM TMAO, 100 μM NADH, 0.1 μM FAD, 100 μg/ml BSA, and 0.3 mM EDTA in 90 mM Tris chloride pH 8.2 and incubated at 37 °C. Ngb reductase activity was assayed by following the absorbance increase at 424 nm in a 1.0-ml anaerobic reaction containing 12 U glucose oxidase, 5 mM glucose, 260 U catalase, 5 μM Ngb, 50 μM NADH, 0.1 μM FAD, 100 μg/ml BSA, and 0.3 mM EDTA in 90 mM Tris chloride buffer, pH 8.2, and incubated at 37 °C. Methyl viologen reductase activity was assayed by following the formation of the blue cation radical at 603 nm and by applying an extinction coefficient of 13,300 M−1 cm−1 in a 1.0-ml anaerobic reaction buffered with 10 mM potassium phosphate, pH 7.0, and containing 12 U glucose oxidase, 5 mM glucose, 260 U catalase, 100 μM NADH, 0.1 μM FAD, 100 μg/ml BSA, 0.3 mM EDTA, and 200 mM sodium chloride and incubated at 37 °C. NO reductase activity was assayed amperometrically at 37 °C in a 1.0-ml anaerobic reaction containing 2 μM NO, 100 μM NADH, 0.1 μM FAD, 12 U glucose oxidase, 5 mM glucose, 260 U catalase, 100 μg/ml BSA, and 0.3 mM EDTA buffered with 10 mM potassium phosphate pH 7.0. CO effects were tested at a final concentration of 50 μM as diluted from a 1 mM stock in water. All activities are reported relative to the heme content of flavoHb.

Model for NOD kinetics and fitting

Rate constants were estimated from the model kinetic equation using Python programming with successive approximations to optimize fits with varying NO and O2 concentrations. Vmax, K1, K2, KT, and Kii(NO) values were treated as independent variables for a given flavoHb while allowing K3, K4, and Ki(NO) to vary over limited ranges with varying O2 concentration. Kii(NO) was estimated from NO inhibition at saturating O2 concentrations. Ki(O2) and Ka(O2) were included as independent variables in order to model the AlaE11 mutant data.

Reduction and ligand binding kinetics

FAD and heme reduction were monitored by following the changes in flavoHb absorbance at 460 and 430 nm, respectively, with stopped-flow rapid mixing of 50 μM NADH and 10 μM flavoHb in N2-purged buffer (4). O2, NO, and CO association rate constants were determined by photolyzing 50 μM of the respective ferrous flavoHb species with a 300-ns pulse from a 577-nm laser and by spectrophotometrically following ligand reassociation in O2-, NO-, or CO-saturated buffer unless otherwise indicated (4, 5). Binding of O2 or CO was measured by the change of absorbance at 436 nm by applying the bound versus unbound difference extinction coefficients of 0.046 and 0.053 μM−1 cm−1, respectively. Binding of NO was measured by the change of absorbance at 422 nm by applying a difference extinction coefficient of 0.040 μM−1 cm−1. O2 and CO dissociation rate constants were determined by stopped-flow rapid mixing with either CO or NO displacement (4, 5). The cuvette path length was 1.0 cm. All reactions were at 20 °C in filtered 100 mM sodium phosphate buffer, pH 7.0, containing 0.3 mM EDTA. Catalase (1000 U/ml) was included in all reactions containing O2 to scavenge H2O2 produced by the NADH oxidase activity of flavoHb and to regenerate O2.

Data analysis

Data are representative of two or more trials. Structures were modeled and analyzed using Jmol version 14.2.15.

Data availability

All data are contained within the manuscript.

Conflict of interest

The authors declare that they have no conflicts of interest with the contents of this article.

Acknowledgments

We thank Arin E. Fletcher for skillful assistance with NOD activity assays, Christopher R. Gessner and Stephen F. Sanders for assistance with the expression and purification of flavoHbs, and Daniel P. Gardner for help with Python programming. We thank Drs John S. Olson and Yi Dou for providing expert assistance in the stopped-flow and laser photolysis measurements. We also thank John Olson for discussions and for initially pointing out discrepancies in the early ping-pong model. We gratefully acknowledge a reviewer for alerting us to signs of a heme potential change in the switching mechanism. P. R. G. dedicates his part in this work to Professor David H. Ives who fostered his early interest in enzymes and their mechanisms.

Author contributions

A. M. G. created expression systems and mutations, expressed, isolated, analyzed the variant flavoHbs, supervised assistants, and assisted in the design of experiments and interpretation of data. P. R. G. designed the experiments, obtained funding, supervised the research, collected, analyzed and interpreted the data, created the mechanistic models, and prepared the manuscript.

Funding and additional information

This work was initiated with funding from the Cincinnati Children's Hospital Research Foundation Trustees, American Heart Association Scientist Development Grant 9730193N, and the National Institutes of Health grant GM65090. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Edited by F. Peter Guengerich

Footnotes

This article contains supporting information.

Present address for Anne M. Gardner: Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio, USA.

Supporting information

Supplementary Figures and Tables
mmc1.pdf (4.1MB, pdf)

References

  • 1.Gardner P.R. Nitric oxide dioxygenase function and mechanism of flavohemoglobin, hemoglobin, myoglobin and their associated reductases. J. Inorg. Biochem. 2005;99:247–266. doi: 10.1016/j.jinorgbio.2004.10.003. [DOI] [PubMed] [Google Scholar]
  • 2.Gardner P.R. Hemoglobin: a nitric-oxide dioxygenase. Scientifica (Cairo) 2012;2012:683729. doi: 10.6064/2012/683729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gardner P.R., Gardner A.M., Martin L.A., Salzman A.L. Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. Proc. Natl. Acad. Sci. U. S. A. 1998;95:10378–10383. doi: 10.1073/pnas.95.18.10378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gardner A.M., Martin L.A., Gardner P.R., Dou Y., Olson J.S. Steady-state and transient kinetics of Escherichia coli nitric-oxide dioxygenase (flavohemoglobin). The B10 tyrosine hydroxyl is essential for dioxygen binding and catalysis. J. Biol. Chem. 2000;275:12581–12589. doi: 10.1074/jbc.275.17.12581. [DOI] [PubMed] [Google Scholar]
  • 5.Gardner P.R., Gardner A.M., Martin L.A., Dou Y., Li T., Olson J.S., Zhu H., Riggs A.F. Nitric-oxide dioxygenase activity and function of flavohemoglobins. Sensitivity to nitric oxide and carbon monoxide inhibition. J. Biol. Chem. 2000;275:31581–31587. doi: 10.1074/jbc.M004141200. [DOI] [PubMed] [Google Scholar]
  • 6.Gardner P.R., Gardner A.M., Brashear W.T., Suzuki T., Hvitved A.N., Setchell K.D., Olson J.S. Hemoglobins dioxygenate nitric oxide with high fidelity. J. Inorg. Biochem. 2006;100:542–550. doi: 10.1016/j.jinorgbio.2005.12.012. [DOI] [PubMed] [Google Scholar]
  • 7.Ouellet H., Ouellet Y., Richard C., Labarre M., Wittenberg B., Wittenberg J., Guertin M. Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 2002;99:5902–5907. doi: 10.1073/pnas.092017799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Couture M., Yeh S.R., Wittenberg B.A., Wittenberg J.B., Ouellet Y., Rousseau D.L., Guertin M. A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 1999;96:11223–11228. doi: 10.1073/pnas.96.20.11223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pathania R., Navani N.K., Gardner A.M., Gardner P.R., Dikshit K.L. Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis haemoglobin, HbN in Escherichia coli. Mol. Microbiol. 2002;45:1303–1314. doi: 10.1046/j.1365-2958.2002.03095.x. [DOI] [PubMed] [Google Scholar]
  • 10.Gardner A.M., Cook M.R., Gardner P.R. Nitric-oxide dioxygenase function of human cytoglobin with cellular reductants and in rat hepatocytes. J. Biol. Chem. 2010;285:23850–23857. doi: 10.1074/jbc.M110.132340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hausladen A., Gow A., Stamler J.S. Flavohemoglobin denitrosylase catalyzes the reaction of a nitroxyl equivalent with molecular oxygen. Proc. Natl. Acad. Sci. U. S. A. 2001;98:10108–10112. doi: 10.1073/pnas.181199698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hausladen A., Stamler J.S. Is the flavohemoglobin a nitric oxide dioxygenase? Free Radic. Biol. Med. 2012;53:1209–1210. doi: 10.1016/j.freeradbiomed.2012.06.033. [DOI] [PubMed] [Google Scholar]
  • 13.Forrester M.T., Foster M.W. Response to “is the flavohemoglobin a nitric oxide dioxygenase”. Free Radic. Biol. Med. 2012;53:1211–1212. doi: 10.1016/j.freeradbiomed.2012.06.033. [DOI] [PubMed] [Google Scholar]
  • 14.Poole R.K. Flavohaemoglobin: the pre-eminent nitric oxide-detoxifying machine of microorganisms. F1000Res. 2020;9 doi: 10.12688/f1000research.20563.1. F1000 Faculty Rev-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Das A.K., Meuwly M. Kinetic analysis and structural interpretation of competitive ligand binding for NO dioxygenation in truncated hemoglobin N. Angew. Chem. Int. Ed. 2018;57:3509–3513. doi: 10.1002/anie.201711445. [DOI] [PubMed] [Google Scholar]
  • 16.Cazade P.-A., Meuwly M. Oxygen migration pathways in NO-bound truncated hemoglobin. Chemphyschem. 2012;13:4276–4286. doi: 10.1002/cphc.201200608. [DOI] [PubMed] [Google Scholar]
  • 17.Liu X., Follmer D., Zweier J.R., Huang X., Hemann C., Liu K., Druhan L.J., Zweier J.L. Characterization of the function of cytoglobin as an oxygen-dependent regulator of nitric-oxide concentration. Biochemistry. 2012;51:5072–5082. doi: 10.1021/bi300291h. [DOI] [PubMed] [Google Scholar]
  • 18.Lechauve C., Butcher J.T., Freiwan A., Biwer L.A., Keith J.M., Good M.E., Ackerman H., Tillman H.S., Kiger L., Isakson B.E., Weiss M.J. Endothelial cell alpha-globin and its molecular chaperone alpha-hemoglobin-stabilizing protein regulate arteriolar contractility. J. Clin. Invest. 2018;128:5073–5082. doi: 10.1172/JCI99933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Doyle M.P., Hoekstra J.W. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J. Inorg. Biochem. 1981;14:351–358. doi: 10.1016/s0162-0134(00)80291-3. [DOI] [PubMed] [Google Scholar]
  • 20.Eich R.F., Li T.S., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Mathews A.J., Johnson K.A., Smith R.D., Phillips G.N., Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry. 1996;35:6976–6983. doi: 10.1021/bi960442g. [DOI] [PubMed] [Google Scholar]
  • 21.Gardner P.R., Martin L.A., Hall D., Gardner A.M. Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Radic. Biol. Med. 2001;31:191–204. doi: 10.1016/s0891-5849(01)00569-x. [DOI] [PubMed] [Google Scholar]
  • 22.Pesce A., Bolognesi M., Nardini M. The diversity of 2/2 (truncated) globins. Adv. Microb. Physiol. 2013;63:49–78. doi: 10.1016/B978-0-12-407693-8.00002-9. [DOI] [PubMed] [Google Scholar]
  • 23.Bustamante J.P., Radusky L., Boechi L., Estrin D.A., Ten Have A., Marti M.A. Evolutionary and functional relationships in the truncated hemoglobin family. PLoS Comput. Biol. 2016;12 doi: 10.1371/journal.pcbi.1004701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Milani M., Pesce A., Ouellet Y., Ascenzi P., Guertin M., Bolognesi M. Mycobacterium tuberculosis hemoglobin N displays a protein tunnel suited for O2 diffusion to the heme. EMBO J. 2001;20:3902–3909. doi: 10.1093/emboj/20.15.3902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Singh S., Thakur N., Oliveira A., Petruk A.A., Hade M.D., Sethi D., Bidon-Chanal A., Marti M.A., Datta H., Parkesh R., Estrin D.A., Luque F.J., Dikshit K.L. Mechanistic insight into the enzymatic reduction of truncated hemoglobin N of Mycobacterium tuberculosis: role of the CD loop and pre-A motif in electron cycling. J. Biol. Chem. 2014;289:21573–21583. doi: 10.1074/jbc.M114.578187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rheault J.F., Gagne E., Guertin M., Lamoureux G., Auger M., Lagüe P. Molecular model of hemoglobin N from Mycobacterium tuberculosis bound to lipid bilayers: a combined spectroscopic and computational study. Biochemistry. 2015;54:2073–2084. doi: 10.1021/bi5010624. [DOI] [PubMed] [Google Scholar]
  • 27.Daigle R., Rousseau J.-A., Guertin M., Lagüe P. Theoretical investigations of nitric oxide channeling in Mycobacterium tuberculosis truncated hemoglobin N. Biophys. J. 2009;97:2967–2977. doi: 10.1016/j.bpj.2009.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bidon-Chanal A., Martí M.A., Estrin D.A., Luque F.J. Dynamical regulation of ligand migration by a gate-opening molecular switch in truncated hemoglobin-N from Mycobacterium tuberculosis. J. Am. Chem. Soc. 2007;129:6782–6788. doi: 10.1021/ja0689987. [DOI] [PubMed] [Google Scholar]
  • 29.Crespo A., Martí M.A., Kalko S.G., Morreale A., Orozco M., Gelpi J.L., Luque F.J., Estrin D.A. Theoretical study of the truncated hemoglobin HbN: exploring the molecular basis of the NO detoxification mechanism. J. Am. Chem. Soc. 2005;127:4433–4444. doi: 10.1021/ja0450004. [DOI] [PubMed] [Google Scholar]
  • 30.Oliveira A., Singh S., Bidon-Chanal A., Forti F., Marti M.A., Boechi L., Estrin D.A., Dikshit K.L., Luque F.J. Role of PheE15 gate in ligand entry and nitric oxide detoxification function of Mycobacterium tuberculosis truncated hemoglobin N. PLoS One. 2012;7 doi: 10.1371/journal.pone.0049291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pesce A., Bustamante J.P., Bidon-Chanal A., Boechi L., Estrin D.A., Luque F.J., Sebilo A., Guertin M., Bolognesi M., Ascenzi P., Nardini M. The N-terminal pre-A region of Mycobacterium tuberculosis 2/2HbN promotes NO-dioxygenase activity. FEBS J. 2016;283:305–322. doi: 10.1111/febs.13571. [DOI] [PubMed] [Google Scholar]
  • 32.Koebke K.J., Waletzko M.T., Pacheco A.A. Direct monitoring of the reaction between photochemically generated nitric oxide and Mycobacterium tuberculosis truncated hemoglobin N wild type and variant forms: an assessment of computational mechanistic predictions. Biochemistry. 2016;55:686–696. doi: 10.1021/acs.biochem.5b01145. [DOI] [PubMed] [Google Scholar]
  • 33.Boron I., Bustamante J.P., Davidge K.S., Singh S., Bowman L.A., Tinajero-Trejo M., Carballal S., Radi R., Poole R.K., Dikshit K., Estrin D.A., Marti M.A., Boechi L. Ligand uptake in Mycobacterium tuberculosis truncated hemoglobins is controlled by both internal tunnels and active site water molecules. F1000Res. 2015;4:22. doi: 10.12688/f1000research.5921.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Martí M.A., Bidon-Chanal A., Crespo A., Yeh S.-R., Guallar V., Luque F.J., Estrin D.A. Mechanism of product release in NO detoxification from Mycobacterium tuberculosis truncated hemoglobin N. J. Am. Chem. Soc. 2008;130:1688–1693. doi: 10.1021/ja076853+. [DOI] [PubMed] [Google Scholar]
  • 35.Smagghe B.J., Trent J.T., 3rd, Hargrove M.S. NO dioxygenase activity in hemoglobins is ubiquitous in vitro, but limited by reduction in vivo. PLoS One. 2008;3 doi: 10.1371/journal.pone.0002039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gabba M., Abbruzzetti S., Spyrakis F., Forti F., Bruno S., Mozzarelli A., Luque F.J., Viappiani C., Cozzini P., Nardini M., Germani F., Bolognesi M., Moens L., Dewilde S. CO rebinding kinetics and molecular dynamics simulations highlight dynamic regulation of internal cavities in human cytoglobin. PLoS One. 2013;8 doi: 10.1371/journal.pone.0049770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.de Sanctis D., Dewilde S., Pesce A., Moens L., Ascenzi P., Hankeln T., Burmester T., Bolognesi M. Mapping protein matrix cavities in human cytoglobin through Xe atom binding. Biochem. Biophys. Res. Commun. 2004;316:1217–1221. doi: 10.1016/j.bbrc.2004.03.007. [DOI] [PubMed] [Google Scholar]
  • 38.Ferreiro D.N., Boechi L., Estrin D.A., Marti M.A. The key role of water in the dioxygenase function of Escherichia coli flavohemoglobin. J. Inorg. Biochem. 2013;119:75–84. doi: 10.1016/j.jinorgbio.2012.10.015. [DOI] [PubMed] [Google Scholar]
  • 39.El Hammi E., Houee-Levin C., Rezac J., Levy B., Demachy I., Baciou L., de la Lande A. New insights into the mechanism of electron transfer within flavohemoglobins: tunnelling pathways, packing density, thermodynamic and kinetic analyses. Phys. Chem. Chem. Phys. 2012;14:13872–13880. doi: 10.1039/c2cp41261f. [DOI] [PubMed] [Google Scholar]
  • 40.Ermler U., Siddiqui R.A., Cramm R., Friedrich B. Crystal structure of the flavohemoglobin from Alcaligenes eutrophus at 1.75 Å resolution. EMBO J. 1995;14:6067–6077. doi: 10.1002/j.1460-2075.1995.tb00297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.El Hammi E., Warkentin E., Demmer U., Marzouki N.M., Ermler U., Baciou L. Active site analysis of yeast flavohemoglobin based on its structure with a small ligand or econazole. FEBS J. 2012;279:4565–4575. doi: 10.1111/febs.12043. [DOI] [PubMed] [Google Scholar]
  • 42.El Hammi E., Warkentin E., Demmer U., Limam F., Marzouki N.M., Ermler U., Baciou L. Structure of Ralstonia eutropha flavohemoglobin in complex with three antibiotic azole compounds. Biochemistry. 2011;50:1255–1264. doi: 10.1021/bi101650q. [DOI] [PubMed] [Google Scholar]
  • 43.Ilari A., Bonamore A., Farina A., Johnson K.A., Boffi A. The X-ray structure of ferric Escherichia coli flavohemoglobin reveals an unexpected geometry of the distal heme pocket. J. Biol. Chem. 2002;277:23725–23732. doi: 10.1074/jbc.M202228200. [DOI] [PubMed] [Google Scholar]
  • 44.Kuki A., Wolynes P.G. Electron tunneling paths in proteins. Science. 1987;236:1647–1652. doi: 10.1126/science.3603005. [DOI] [PubMed] [Google Scholar]
  • 45.Hoshino M., Ozawa K., Seki H., Ford P.C. Photochemistry of nitric oxide adducts of water-soluble iron(III) porphyrin and ferrihemoproteins studied by nanosecond laser photolysis. J. Am. Chem. Soc. 1993;115:9568–9575. [Google Scholar]
  • 46.Segel I.H. John Wiley & Sons, Inc; New York, NY: 1975. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. [Google Scholar]
  • 47.Ferreiro D.U., Komives E.A., Wolynes P.G. Frustration in biomolecules. Q. Rev. Biophys. 2014;47:285–363. doi: 10.1017/S0033583514000092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 1993;18:195–199. doi: 10.3109/10715769309145868. [DOI] [PubMed] [Google Scholar]
  • 49.Mukai M., Mills C.E., Poole R.K., Yeh S.R. Flavohemoglobin, a globin with a peroxidase-like catalytic site. J. Biol. Chem. 2001;276:7272–7277. doi: 10.1074/jbc.M009280200. [DOI] [PubMed] [Google Scholar]
  • 50.Giordano D., Pesce A., Vermeylen S., Abbruzzetti S., Nardini M., Marchesani F., Berghmans H., Seira C., Bruno S., Javier Luque F., di Prisco G., Ascenzi P., Dewilde S., Bolognesi M., Viappiani C. Structural and functional properties of Antarctic fish cytoglobins-1: cold-reactivity in multi-ligand reactions. Comput. Struct. Biotechnol. J. 2020;18:2132–2144. doi: 10.1016/j.csbj.2020.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Helmick R.A., Fletcher A.E., Gardner A.M., Gessner C.R., Hvitved A.N., Gustin M.C., Gardner P.R. Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin. Antimicrob. Agents Chemother. 2005;49:1837–1843. doi: 10.1128/AAC.49.5.1837-1843.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Cooper C.E., Ioannidis N., D'Mello R., Poole R.K. Haem, flavin and oxygen interactions in Hmp, a flavohaemoglobin from Escherichia coli. Biochem. Soc. Trans. 1994;22:709–713. doi: 10.1042/bst0220709. [DOI] [PubMed] [Google Scholar]
  • 53.Noble R.W., De Young A., Vitale S., Morante S., Cerdonio M. Studies on the linkage between spin equilibria and protein structure in carp ferric hemoglobin. Eur. J. Biochem. 1987;168:563–567. doi: 10.1111/j.1432-1033.1987.tb13454.x. [DOI] [PubMed] [Google Scholar]
  • 54.Goldstein S., Merenyi G., Samuni A. Kinetics and mechanism of •NO2 reacting with various oxidation states of myoglobin. J. Am. Chem. Soc. 2004;126:15694–15701. doi: 10.1021/ja046186+. [DOI] [PubMed] [Google Scholar]
  • 55.Blomberg L.M., Blomberg M.R., Siegbahn P.E. A theoretical study of myoglobin working as a nitric oxide scavenger. J. Biol. Inorg. Chem. 2004;9:923–935. doi: 10.1007/s00775-004-0585-5. [DOI] [PubMed] [Google Scholar]
  • 56.Yukl E.T., de Vries S., Moënne-Loccoz P. The millisecond intermediate in the reaction of nitric oxide with oxymyoglobin is an iron(III)--nitrato complex, not a peroxynitrite. J. Am. Chem. Soc. 2009;131:7234–7235. doi: 10.1021/ja9026924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Šrajer V., Teng T.-y., Ursby T., Pradervand C., Ren Z., Adachi S.-i., Schildkamp W., Bourgeois D., Wulff M., Moffat K. Photolysis of the carbon monoxide complex of myoglobin: nanosecond time-resolved crystallography. Science. 1996;274:1726–1729. doi: 10.1126/science.274.5293.1726. [DOI] [PubMed] [Google Scholar]
  • 58.Šrajer V., Ren Z., Teng T.-Y., Schmidt M., Ursby T., Bourgeois D., Pradervand C., Schildkamp W., Wulff M., Moffat K. Protein conformational relaxation and ligand migration in myoglobin:  a nanosecond to millisecond molecular movie from time-resolved Laue X-ray diffraction. Biochemistry. 2001;40:13802–13815. doi: 10.1021/bi010715u. [DOI] [PubMed] [Google Scholar]
  • 59.Frauenfelder H., Chen G., Berendzen J., Fenimore P.W., Jansson H., McMahon B.H., Stroe I.R., Swenson J., Young R.D. A unified model of protein dynamics. Proc. Natl. Acad. Sci. U. S. A. 2009;106:5129–5134. doi: 10.1073/pnas.0900336106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Bourgeois D., Vallone B., Schotte F., Arcovito A., Miele A.E., Sciara G., Wulff M., Anfinrud P., Brunori M. Complex landscape of protein structural dynamics unveiled by nanosecond Laue crystallography. Proc. Natl. Acad. Sci. U. S. A. 2003;100:8704–8709. doi: 10.1073/pnas.1430900100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Terrell J.R., Gumpper R.H., Luo M. Hemoglobin crystals immersed in liquid oxygen reveal diffusion channels. Biochem. Biophys. Res. Commun. 2018;495:1858–1863. doi: 10.1016/j.bbrc.2017.12.038. [DOI] [PubMed] [Google Scholar]
  • 62.Teng C.L., Bryant R.G. Mapping oxygen accessibility to ribonuclease A using high-resolution NMR relaxation spectroscopy. Biophys. J. 2004;86:1713–1725. doi: 10.1016/S0006-3495(04)74240-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Bryant R.G. The dynamics of water-protein interactions. Annu. Rev. Biophys. Biomol. Struct. 1996;25:29–53. doi: 10.1146/annurev.bb.25.060196.000333. [DOI] [PubMed] [Google Scholar]
  • 64.Miranda J.J., Maillett D.H., Soman J., Olson J.S. Thermoglobin, oxygen-avid hemoglobin in a bacterial hyperthermophile. J. Biol. Chem. 2005;280:36754–36761. doi: 10.1074/jbc.M505918200. [DOI] [PubMed] [Google Scholar]
  • 65.Corti P., Xue J., Tejero J., Wajih N., Sun M., Stolz D.B., Tsang M., Kim-Shapiro D.B., Gladwin M.T. Globin X is a six-coordinate globin that reduces nitrite to nitric oxide in fish red blood cells. Proc. Natl. Acad. Sci. U. S. A. 2016;113:8538–8543. doi: 10.1073/pnas.1522670113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Gardner P.R., Gardner D.P., Gardner A.P. Globins scavenge sulfur trioxide anion radical. J. Biol. Chem. 2015;290:27204–27214. doi: 10.1074/jbc.M115.679621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Gardner A.M., Helmick R.A., Gardner P.R. Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli. J. Biol. Chem. 2002;277:8172–8177. doi: 10.1074/jbc.M110471200. [DOI] [PubMed] [Google Scholar]
  • 68.Gardner A.M., Gardner P.R. Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli. Evidence for a novel inducible anaerobic nitric oxide-scavenging activity. J. Biol. Chem. 2002;277:8166–8171. doi: 10.1074/jbc.M110470200. [DOI] [PubMed] [Google Scholar]
  • 69.Frauenfelder H., McMahon B.H., Austin R.H., Chu K., Groves J.T. The role of structure, energy landscape, dynamics, and allostery in the enzymatic function of myoglobin. Proc. Natl. Acad. Sci. U. S. A. 2001;98:2370–2374. doi: 10.1073/pnas.041614298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Beck von Bodman S., Schuler M.A., Jollie D.R., Sligar S.G. Synthesis, bacterial expression, and mutagenesis of the gene coding for mammalian cytochrome b5. Proc. Natl. Acad. Sci. U. S. A. 1986;83:9443–9447. doi: 10.1073/pnas.83.24.9443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Yanisch-Perron C., Viera J., Messing J. Improved M13 phage cloning vector and host strains: nucleotide sequence of the Ml3mp19 and pUC19 vectors. Gene (Amst.) 1985;33:103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  • 72.Gardner P.R. Assay and characterization of the NO dioxygenase activity of flavohemoglobins. Methods Enzymol. 2008;436:217–237. doi: 10.1016/S0076-6879(08)36012-1. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figures and Tables
mmc1.pdf (4.1MB, pdf)

Data Availability Statement

All data are contained within the manuscript.


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES